|
- 积分
- 42
- 威望
- 42
- 包包
- 486
|
本帖最后由 aaaszw 于 2016-12-9 09:16 编辑 " l. C4 T- C4 b4 K& o1 M7 c
; a2 a0 {' F6 g$ l3 ~3 C8 b
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.4 k. [, b& I, @7 O. m# C4 f5 D) B
https://www.ncbi.nlm.nih.gov/pubmed/27912061/ Q: D4 c2 o* z
3 ]" i! N- {4 F) Q$ v8 x% IThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
4 M; K, x- X" K8 Y: r& l% @https://www.ncbi.nlm.nih.gov/pubmed/27525555
: f! E* Y" o* L1 z
, }" Y6 _$ ^' O2 s) I1 v3 ~Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion' g2 Y: z2 U+ b' K/ L# c
https://www.ncbi.nlm.nih.gov/pubmed/27496729
6 g3 e" W* ?0 H& g$ K+ ~0 V1 l$ q/ F1 T" x% Q3 ^2 L" {. \1 f
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.
, {" W2 a* W# g b- T7 Thttps://www.ncbi.nlm.nih.gov/pubmed/27430722
, @ ^) [7 G3 M' q
* A+ H$ \9 ~' H9 R( ]9 a% T. ^; o! ]Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
' f3 S% O9 V5 u& Mhttps://www.ncbi.nlm.nih.gov/pubmed/27192569
# A# a! }% _% ~3 O
3 R' v) A1 u( ICombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling. ]7 |. @4 R7 m9 {# y+ E
https://www.ncbi.nlm.nih.gov/pubmed/27058661, w2 {. U7 q1 ]$ N/ s
1 ?* ^. O" F' V0 M2 W& zDe-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute |" O c, h1 C2 G. y
https://www.ncbi.nlm.nih.gov/pubmed/27036972 |
|
发表于 2016-12-9 09:15
